Living donor transplant options in end-stage renal disease patients with ABO incompatibility

Indian Journal of Urology

Volumn 29, Issue 2, 2013, Pages 114-118

  Waigankar, Santosh S ^a   Kamat, Madhav H ^a   Joshi, Shriram ^a   Gandhi, Bhupendra V ^a   Bahadur, Madan ^a   Deshpande, Rushi V ^a  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

ABO incompatibility; CKD 5; Living donor; Paired kidney exchange transplants; Rituximab; Splenectomy

Indexed keywords

AMYLASE; BLOOD CLOTTING FACTOR 7; CREATININE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; TACROLIMUS;

ACUTE GRAFT REJECTION; AMYLASE BLOOD LEVEL; ARTICLE; B CELL LYMPHOMA; BLOOD GROUP ABO INCOMPATIBILITY; COMMUNITY ACQUIRED PNEUMONIA; DEVELOPING COUNTRY; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KIDNEY VEIN THROMBOSIS; LIVING DONOR; LOW DRUG DOSE; LYMPHATIC DRAINAGE; NEPHRECTOMY; OPERATING ROOM; PARALYTIC ILEUS; PLASMAPHERESIS; POSTOPERATIVE PERIOD; RENAL ARTERY THROMBOSIS; SEPTICEMIA; SEROLOGY; SPLENECTOMY; TREATMENT DURATION;

EID: 84880303914     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.114031     Document Type: Article

References (10)

1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Eng J Med 1999;341:1725-30
2. Veerappan I, Neelakantan N, Tamilarasi V, John GT. Medical and nonmedical factors that affects voluntary living-related kidney donation: A single-centre study. Indian J Nephrol 2011;21:14-20
3. Government of India. Transplantation of Human Organs Act, 1994. Central Act 42 of 1994. Available from: http://mohfw.nic.in/WriteReadData/l892s/ S12011122007MS-18018705.pdf
4. The Report of Transplant of Human Organs Act Review Committee. Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India; 2005. Available from: http://www. mohanfoundation.org/tho/ thoa-review-committee.asp
5. Gazette-Transplantation of Human Organs Rules. 1995. (GSR NO. 51(E), dr 4-2-1995) [As amended vide GSR 571(E), dt31-7-2008] [cited 2008 Jul] Available from: http://wwwmedindianet/indian-health-act/The-Transplantation-of-Human- Organ-Rules-1995-Definitions.htm
6. Tydén G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigenspecific immunoadsorption and rituximab. Am J Transplant 2005;5:145-8
7. Fuchinoue S, Ishii Y, Sawada T, Murakami T, Iwadoh K, Sannomiya A, et al. The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction. Transplantation 2011;91:853-7
8. United Network for Organ Sharing Web site. Organ procurement and transplantation network data. Available at: http://www.unos.org. Accessed March 10, 2005
9. Montgomery RA, Zachary AA, Ratner LE, Segev DL, Hiller JM, Houp J, et al. Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA 20055;294:1655-63
10. Modi P, Rizvi SJ, Pal B, Baradwaj R, Gupta S, Shah V, et al. Living donor paired-kidney exchange transplantation: A single institution experience. Indian J Urol 2010;26:511-4